DAMPening ARDS & VILI Inflammation with a Novel Biologic Targeting eNAMPT

Time: 1:30 pm
day: Day One


• Understanding the role of DAMPs in driving ARDS mortality and what it means for drug developers
• Revealing the challenges and lessons learned when searching for Novel ARDS Targets- eNAMPT
• Exploring the efficacy of anti-inflammatory mAbs in preclinical ARDS/ VILI models